AACR 2026 Recap: The Science Behind Spatial Biology, Multi-Omics, and What’s Ahead
What a week. The American Association for Cancer Research Annual Meeting brought together over 20,000 of the brightest minds in oncology and booth #2061 was alive with it.
From deep dives on spatial workflows, NGS, and multi-omics to translational research strategy, we had the privilege of connecting with researchers, clinicians, and biopharma teams doing remarkable work and learning how Admera's services can help move it forward.
The Conversations That Defined the Floor
If AACR 2026 had a defining theme, it was spatial biology. Researchers aren't just curious anymore, they're planning studies, scoping budgets, and asking hard questions about how spatial fits into their existing workflows.
Most notably, spatial is crossing into clinical conversations, and that changes everything.
The Single-Cell RNA-seq Shift is Real
Every cell has a location. Are you reading the map?
Go beyond single-cell resolution & discover where gene expression happens within tissue architecture.
Learn More
Alongside spatial, single-cell RNA-seq is gaining serious momentum. More labs are moving beyond bulk methods to capture the cellular resolution their science demands and we're seeing more projects that integrate both.
Admera supports the full spectrum, from Spatial Transcriptomics Services to Single-cell RNA-seq to end-to-end analysis pipelines, powered by cutting-edge technology. Whether you're mapping the tumor microenvironment or characterizing immune infiltration, we have the workflows and expertise to get you there.
Beyond the Buzz: Quality Beyond Industry Standards
Spatial transcriptomics was front and center, but it wasn't the only thing on researchers' minds. What kept surfacing was more fundamental: reliable quality data, transparent pricing, and a partner who communicates.
At Admera, those have never been optional. One thing that consistently resonated is our ability to handle challenging sample types like bone, skin, FFPE, and more. Where other providers struggle, we've built deep expertise. It's not a workaround. It's what we do.
Our NGS and multi-omics services are built around high-quality data delivery, straightforward project management, and PhD scientific support from start to finish because your research deserves more than a transaction.
That same standard runs through our bioinformatics data analysis services: rigorous, reproducible, and delivered with PhD-level interpretation so your results are actionable from day one. From raw sequencing reads through single-cell RNA-seq analysis pipelines to publication-ready outputs, every step is held to a higher bar.
What's Next
The badges are off, but this week is where the real work begins. Our team is actively following up on every conversation from the show and if we didn't connect in person, it's not too late.
Meet the Team Who Represented Admera Health
The team was all smiles at #AACR26
Sarah Deeb, Sales Executive, M.S.
Five years in NGS, with a sharp ability to translate complex sequencing challenges into actionable research plans. Sarah bridges science and strategy so your project moves forward not sideways. [email protected]
Joey Qiu, Senior Sales Executive, M.S. With 15+ years across NGS and multi-omics along with deep roots in molecular biology, Joey is a trusted partner for academic labs and biopharma oncology teams tackling their most demanding projects. [email protected]
Sumant Grover, Sales Executive, Ph.D. Sumant brings scientific depth to every conversation — from early-stage study design to complex collaborative workflows. If your project needs a PhD thought partner, start here. [email protected]
Admera Health provides end-to-end genomic services including NGS, multi-omics, and spatial biology solutions for academic, clinical, and biopharma research. Learn more at admerahealth.com.